Cardioprotective Effects of Dapagliflozin Against Radiotherapy Induced Cardiac Damage
Open Access
- 1 January 2025
- journal article
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 29 (4) , 193-200
Abstract
With the increasing incidence of cancer among the adult population, radiotherapy (RT) is frequently used as a critical component in the treatment of various cancer types. Due to the nature of ionizing radiation, damage usually occurs within the tissues in anatomical neighborhood with the primary tumor localization. Dapagliflozin (DAPA), originally developed as an oral anti-diabetic medication, has been shown to have potent cardioprotective effects in the DAPA-HF trial. The cardioprotective effects of DAPA against RT induced cardiac cellular damage were investigated in this study. A total of 40 male Wistar albino rats were obtained and were subjected to a 10-day pretreatment period to accommodate laboratory settings. Afterwards, the rats were divided into 4 groups consisting of 10 each (control = 10, DAPA = 10, RT = 10, RT + DAPA = 10). Meanwhile, the RT and RT + DAPA groups received a single dose of 20 Gray (Gy) x-ray to 4 × 4 cm area at 0.60 Gy/min, and DAPA and RT + DAPA groups were gavaged daily with 10 mg/kg DAPA. In the second week of the study, rats were examined by echocardiography and electrocardiogram. Furthermore, histopathological method was used to evaluate the level of cardiotoxicity. The ejection fraction value decreased by 17.3% lower in the DAPA + RT group compared with the RT group (P < .001). In addition, corrected QT interval prolongation and QRS widening were 11.5% and 17.4% higher in the RT group compared with the DAPA + RT group, respectively (P < .001 for both values). While sarcomyolysis, inflammatory cell infiltration, and necrotic changes were found to be severe in the RT group, the DAPA + RT group had 68% less sarcomyolysis, 64% less inflammatory cell infiltration, and 55% less necrosis (P < .001 for all values). The protective effects of DAPA against left ventricular remodeling and dysfunction in RT-induced cardiomyopathy model were observed in this study.Keywords
This publication has 27 references indexed in Scilit:
- Cardiac Toxicity After Radiotherapy for Stage III Non–Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 GyJournal of Clinical Oncology, 2017
- Effects of ionizing radiation on the heartMutation Research - Reviews in Mutation Research, 2016
- Novel concepts in radiation-induced cardiovascular diseaseWorld Journal of Cardiology, 2016
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyThe Lancet Oncology, 2015
- Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat modelPathology - Research and Practice, 2014
- How to calculate sample size in animal studies?Journal of Pharmacology and Pharmacotherapeutics, 2013
- Long-term effects of acute low-dose ionizing radiation on the neonatal mouse heart: a proteomic studyRadiation and Environmental Biophysics, 2013
- Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular DiseaseCurrent Atherosclerosis Reports, 2012
- Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodelingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Radiation-induced changes in the ultrastructure and mechanical function of the rat heartRadiotherapy and Oncology, 1989